Abstract
Purpose
Ectopic parathyroid carcinoma (EPC) is a rare clinical entity with multiple diagnostic pitfalls, making surgical cures challenging. We assessed the clinicopathological spectrum and outcome of EPCs.
Methods
In this retrospective cohort study, 24 EPCs were identified from 133 PC patients treated at a tertiary referral center. The relationship between clinicopathological findings and locations was analyzed.
Results
The locations of EPCs were predominantly intrathyroidal (62.5%), followed by 16.7% in the mediastinum, 8.3% in the retropharyngeal space, 8.3% in the carotid sheath, and 4.2% in the upper neck. Intrathyroidal EPC patients experienced higher serum calcium (p = 0.020), a higher rate of vascular invasion (p = 0.040), and a slightly higher incidence of non-R0 initial resection (p = 0.092) than those in other ectopic locations. Intrathyroidal EPC patients also suffered a trend of higher upper aerodigestive tract (UAT) invasion rate (p = 0.070) and higher risks of distant metastasis (p = 0.037) than the other PC patients. The 5-year disease-free survival rate after surgery was slightly compromised at 41.5% in intrathyroidal EPC patients compared with 77.8% among those in other ectopic locations (p = 0.143) and 59.7% among the other PC patients (log-rank = 3.194; p = 0.074), though without statistical significance.
Conclusion
Intrathyroidal EPC might cause a more biochemically and invasively distinct PC picture compared with other PCs. Special caution should be exercised in the preoperative diagnosis and management of such cases.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03964-4/MediaObjects/12020_2024_3964_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03964-4/MediaObjects/12020_2024_3964_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03964-4/MediaObjects/12020_2024_3964_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03964-4/MediaObjects/12020_2024_3964_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03964-4/MediaObjects/12020_2024_3964_Fig5_HTML.png)
References
E. Shane, Clinical review 122: Parathyroid carcinoma. J. Clin. Endocrinol. Metab. 86(2), 485–493 (2001). https://doi.org/10.1210/jcem.86.2.7207
A.S. Salcuni, F. Cetani, V. Guarnieri, V. Nicastro, E. Romagnoli, D. de Martino et al. Parathyroid carcinoma. Best Pract. Res. Clin. Endocrinol. Metab. 32(6), 877–889 (2018). https://doi.org/10.1016/j.beem.2018.11.002
S. Xue, H. Chen, C. Lv, X. Shen, J. Ding, J. Liu et al. Preoperative diagnosis and prognosis in 40 parathyroid carcinoma patients. Clin. Endocrinol. 85(1), 29–36 (2016). https://doi.org/10.1111/cen.13055
N. Talat, K.M. Schulte, Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann. Surg. Oncol. 17(8), 2156–2174 (2010). https://doi.org/10.1245/s10434-010-1003-6
A. Harari, A. Waring, G. Fernandez-Ranvier, J. Hwang, I. Suh, E. Mitmaker et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J. Clin. Endocrinol. Metab. 96(12), 3679–3686 (2011). https://doi.org/10.1210/jc.2011-1571
C.H. Wei, A. Harari, Parathyroid carcinoma: update and guidelines for management. Curr. Treat. Options Oncol. 13(1), 11–23 (2012). https://doi.org/10.1007/s11864-011-0171-3
A. Al-Kurd, M. Mekel, H. Mazeh, Parathyroid carcinoma. Surg. Oncol. 23(2), 107–114 (2014). https://doi.org/10.1016/j.suronc.2014.03.005
M. Roy, H. Mazeh, H. Chen, R.S. Sippel, Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J. Surg. 37(1), 102–106 (2013). https://doi.org/10.1007/s00268-012-1773-z
R.D. Gaz, P.B. Doubler, C.A. Wang, The management of 50 unusual hyperfunctioning parathyroid glands. Surgery. 102(6), 949–957 (1987)
N. Poortmans, G. Verfaillie, D. Unuane, S. Raeymaeckers, J. Lamote, Intrathyroidal parathyroid carcinoma presenting as an asymptomatic hypercalcemia: a case report. Acta Chir. Belg. 120(6), 433–436 (2020). https://doi.org/10.1080/00015458.2019.1631626
M.I. Cook, Y.A. Qureshi, C.E. Todd, R.S. Cummins, An unusual ectopic location of a parathyroid carcinoma arising within the thyroid gland. J. Clin. Endocrinol. Metab. 97(6), 1829–1833 (2012). https://doi.org/10.1210/jc.2011-3115
Y. **n, T. Zhao, B. Wei, H. Gu, M. **, H. Shen et al. Intrapericardial parathyroid carcinoma: a case report. Endocrine 69(2), 456–460 (2020). https://doi.org/10.1007/s12020-020-02283-8
S.V. Gowrishankar, R. Bidaye, T. Das, V. Majcher, B. Fish, R. Casey et al. Intrathyroidal parathyroid adenomas: Sco** review on clinical presentation, preoperative localization, and surgical treatment. Head Neck 45(3), 706–720 (2023). https://doi.org/10.1002/hed.27287
W. Zhao, R. Lu, L. Yin, B. Wei, M. **, C. Zhang et al. The value of preoperative and intraoperative ultrasound in the localization of intrathyroidal parathyroid adenomas. J. Invest. Surg. 35(4), 752–757 (2022). https://doi.org/10.1080/08941939.2021.1933273
B. Wei, T. Zhao, H. Shen, M. **, Q. Zhou, X. Liu et al. Extended en bloc reoperation for recurrent or persistent parathyroid carcinoma: Analysis of 31 cases in a single institute experience. Ann. Surg. Oncol. 29(2), 1208–1215 (2022). https://doi.org/10.1245/s10434-021-10962-7
A.M. Parikh, J.W. Suliburk, F.E. Morón, Imaging localization and surgical approach in the management of ectopic parathyroid adenomas. Endocr. Pract. 24(6), 589–598 (2018). https://doi.org/10.4158/EP-2018-0003
G. Noussios, P. Anagnostis, K. Natsis, Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp. Clin. Endocrinol. Diabetes. 120(10), 604–610 (2012). https://doi.org/10.1055/s-0032-1327628
M.B. Albuja-Cruz, B.J. Allan, P.P. Parikh, J.I. Lew, Efficacy of localization studies and intraoperative parathormone monitoring in the surgical management of hyperfunctioning ectopic parathyroid glands. Surgery 154(3), 453–460 (2013). https://doi.org/10.1016/j.surg.2013.05.034
S.G. Haciyanli, S. Karaisli, N. Erdogan, B. Turgut, E.O. Gur, M. Haciyanli, Intrathyroidal parathyroid adenomas in primary hyperparathyroidism: Clinical and imaging findings. Sisli Etfal Hastan. Tip Bul. 56(2), 256–261 (2022). https://doi.org/10.14744/SEMB.2022.82584
J.S. Andrade, J.P. Mangussi-Gomes, L.A. Rocha, M.N. Ohe, M. Rosano, M.C. das Neves et al. Localization of ectopic and supernumerary parathyroid glands in patients with secondary and tertiary hyperparathyroidism: surgical description and correlation with preoperative ultrasonography and Tc99m-Sestamibi scintigraphy. Braz. J. Otorhinolaryngol. 80(1), 29–34 (2014). https://doi.org/10.5935/1808-8694.20140008
C. Vulpio, M. Bossola, A. De Gaetano, G. Maresca, I. Bruno, G. Fadda et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32(9), 1226–1235 (2010). https://doi.org/10.1002/hed.21320
S. Tseleni-Balafouta, H. Gakiopoulou, N. Kavantzas, G. Agrogiannis, N. Givalos, E. Patsouris, Parathyroid proliferations: a source of diagnostic pitfalls in FNA of thyroid. Cancer 111(2), 130–136 (2007). https://doi.org/10.1002/cncr.22576
H. Ketha, M.A. Lasho, A. Algeciras-Schimnich, Analytical and clinical validation of parathyroid hormone (PTH) measurement in fine-needle aspiration biopsy (FNAB) washings. Clin. Biochem. 49(1-2), 16–21 (2016). https://doi.org/10.1016/j.clinbiochem.2015.09.006
C. Glasgow, E.Y.C. Lau, L. Aloj, I. Harper, H. Cheow, T. Das et al. An approach to a patient with primary hyperparathyroidism and a suspected ectopic parathyroid adenoma. J. Clin. Endocrinol. Metab. 107(6), 1706–1713 (2022). https://doi.org/10.1210/clinem/dgac024
Y. Hu, Y. Bi, M. Cui, X. Zhang, Z. Su, M. Wang et al. The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute. Endocr. Pract. 25(7), 634–641 (2019). https://doi.org/10.4158/EP-2018-0538
Y. Chen, A. Song, M. Nie, Y. Jiang, M. Li, W. **a et al. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort. Front. Endocrinol. 14, 1027598 (2023). https://doi.org/10.3389/fendo.2023.1027598
T. Zhao, W. Yang, R. Shen, Q. Chen, M. **, H. Gu et al. Risk factors of distant metastatic parathyroid carcinoma and insights into therapeutic perspectives. Ann. Surg. Oncol. (2024). https://doi.org/10.1245/s10434-024-15611-3
Acknowledgements
We would like to thank Prof. Bin Hu for invaluable technical guidance. This study was supported by the Bei**g Municipal Administration of Hospitals Incubating Program (PX2023009) and the National Natural Science Foundation of China (82200872).
Author information
Authors and Affiliations
Contributions
T. Zhao, J. H., Y. W., and B. W. contributed to the study conception and design. T. Zhao, J. H., Y. W., H. S., X. L., D. F., J. W., and Q. W. collected all data. T. Zhao, D. Z., T. Zhang, R. L., H. G., M. J., and B. W. analyzed and interpreted all data. The main manuscript was written by T. Zhao and J. H. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Ethics approval
This is a retrospective cohort study. The study was approved by the ethics committee of Bei**g Chaoyang Hospital.
Informed consent
Written informed consent was obtained from all patients included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhao, T., Huang, J., Wang, Y. et al. Clinicopathological spectrum, management, and outcome of ectopic parathyroid carcinoma: Experience with 24 cases. Endocrine (2024). https://doi.org/10.1007/s12020-024-03964-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03964-4